Clinical Trial Update: Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vincristine and irinotecan with or without temozolomide in refractory/relapsed rhabdomyosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: RHABDOMYOSARCOMA | Phase 2 | Status: COMPLETED